HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Raimon Sanmarti Selected Research
Raimon Sanmarti Research Topics
Disease
19
Rheumatoid Arthritis
03/2022 - 04/2003
4
Psoriatic Arthritis
12/2018 - 05/2012
3
Synovitis
01/2022 - 08/2014
3
Necrosis
01/2018 - 11/2012
2
Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 01/2020
2
Palindromic rheumatism
01/2020 - 08/2014
2
Ankylosing Spondylitis
01/2019 - 06/2009
2
Arthritis (Polyarthritis)
01/2019 - 01/2018
1
Hypersensitivity (Allergy)
09/2021
1
Pain (Aches)
01/2019
1
Juvenile Arthritis (Juvenile Idiopathic Arthritis)
12/2018
1
Rheumatic Diseases (Rheumatism)
05/2018
1
Joint Diseases (Joint Disease)
01/2016
1
Respiratory Tract Infections (Respiratory Tract Infection)
06/2009
1
Infections
06/2009
1
Headache (Headaches)
06/2009
1
Injection Site Reaction
06/2009
Drug/Important Bio-Agent (IBA)
5
Leukocyte L1 Antigen Complex (Calgranulin)
IBA
03/2022 - 12/2015
5
Proteins (Proteins, Gene)
FDA Link
09/2021 - 08/2014
5
Etanercept (Enbrel)
FDA Link
01/2016 - 06/2009
4
tocilizumab (atlizumab)
FDA Link
10/2019 - 12/2015
4
Infliximab (Remicade)
FDA Link
01/2019 - 01/2008
3
Tumor Necrosis Factor Inhibitors
IBA
12/2018 - 11/2012
3
Acute-Phase Proteins (Acute-Phase Protein)
IBA
01/2016 - 12/2015
3
Adalimumab (Humira)
FDA Link
01/2016 - 08/2015
2
C-Reactive Protein
IBA
01/2022 - 01/2016
2
Antibodies
IBA
01/2022 - 09/2021
2
Interleukin-6 (Interleukin 6)
IBA
01/2022 - 01/2018
2
Autoantibodies
IBA
01/2022 - 01/2020
2
Pharmaceutical Preparations
IBA
01/2018 - 01/2016
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
05/2012 - 01/2008
1
Janus Kinase Inhibitors
IBA
01/2022
1
Immunoglobulin E (IgE)
IBA
09/2021
1
Abatacept (Orencia)
FDA Link
09/2021
1
Anti-Idiotypic Antibodies
IBA
01/2020
1
Peptides (Polypeptides)
IBA
01/2020
1
HLA-B27 Antigen (HLA B27 Antigen)
IBA
01/2019
1
Glucocorticoids
IBA
01/2019
1
Biomarkers (Surrogate Marker)
IBA
12/2018
1
Methotrexate (Mexate)
FDA Link
Generic
05/2018
1
Rituximab (Mabthera)
FDA Link
11/2012
1
N 30
IBA
06/2009
1
HLA-DRB1 Chains (HLA DRB1)
IBA
01/2008
1
Antirheumatic Agents (DMARD)
IBA
04/2003
Therapy/Procedure
2
Therapeutics
01/2019 - 01/2018
1
Biological Therapy
05/2012